The mean (SD) severity of dysmenorrhea pain on a VAS was reduced from 4.33 (2.92) cm at baseline to 2.01 (2.26) cm at Cycle 5 and showed a decreasing trend throughout the study.
← all excerpts
An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open-label multicenter clinical study.
1
—
—